Evidence map›Paper›PMID 39524215›Full record

ArticleCurrent developments in nutrition2024

Health Claims, Product Features and Instructions for Use on the Labels of Potassium-enriched Salt Products: A Content Analysis.

James Bullen, Xuejun Yin, Katrina Kissock, Laura Fisher, Bruce Neal, Kathy Trieu

Abstract read
In one paragraph

Article in Current developments in nutrition, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

James BullenThe George Institute for Global Health, University of New South Wales, New South Wales, Australia.
Xuejun YinThe George Institute for Global Health, University of New South Wales, New South Wales, Australia.
Katrina KissockThe George Institute for Global Health, University of New South Wales, New South Wales, Australia.
Laura FisherThe George Institute for Global Health, University of New South Wales, New South Wales, Australia.
Bruce NealThe George Institute for Global Health, University of New South Wales, New South Wales, Australia.
Kathy TrieuThe George Institute for Global Health, University of New South Wales, New South Wales, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Potassium-enriched salt is a proven dietary intervention for reducing risk of stroke, cardiovascular disease, and premature mortality when used instead of regular table salt. Potassium-enriched salt products are available globally, but the on-pack health claims, product features, and instructions for use are diverse. Objectives: The objective of this study was to summarize the label features of potassium-enriched salt products available worldwide. Methods: A content analysis was conducted on the labels of potassium-enriched salt products available for sale in May 2023. Potassium-enriched salt products were identified through a systematic search of literature, major online shopping websites, and Google using similar keywords such as "salt substitute" or "low sodium salt." Information on product labels was coded relating to health claims, product features, and instructions for use, and were quantitatively summarized. Results: A total of 117 potential potassium-enriched salt products were identified, with 83 included in the final analysis after excluding products containing no sodium ( Conclusions: There was large variability in the label features of potassium-enriched salt products identified in this study. Most product labels made no health-related statements, but among those that did, warnings occurred more frequently than statements of health benefits. The diversity in labeling may cause confusion among consumers, and standardized, evidence-based labeling should be developed.

Indexed as

blood pressurecardiovascular diseasecontent analysislabelinglow-sodium saltpotassium chloridepotassium-enriched saltsalt substitutesodium chloridesodium reduction

Identifiers

PMID39524215
PMCPMC11547896

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.